Buscar
Mostrando ítems 1-10 de 35
Avaliação crítica do sevelamer no tratamento da hiperfosfatemia em pacientes com insuficiência renal crônica
(Associação Médica Brasileira, 2003-01-01)
OBJECTIVE: To evaluate in patients with chronic renal failure (CRF) the effectiveness and the costs of sevelamer, a cationic polymer calcium- and aluminum-free, that is a new gastrointestinal phosphate binder. METHODS: ...
EFICACIA DEL CARBONATO DE LANTANO FRENTE AL SEVELAMER EN EL MANEJO DE LA HIPERFOSFATEMIA EN PACIENTES ADULTOS CON ENFERMEDAD RENAL CRÓNICA
(Universidad Privada Norbert Wiener, 2019-10-20)
Objetivo: Sistematizar las evidencias sobre la eficacia del carbonato de lantano frente al sevelamer para el manejo de la hiperfosfatemia en pacientes adultos con insuficiencia renal crónica. Materiales y métodos: Las 10 ...
Familial tumoral calcinosis caused by a novel FGF23 mutation: Response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer
(2009)
Hyperphosphatemic familial tumoral calcinosis (HFTC) is an uncommon disease characterized by periarticular calcifications produced by the deposition of amorphous extraosseous calcifications of hydroxyapatite. It is associated ...
Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders
(AMER SOC NEPHROLOGY, 2010)
Most patients with chronic kidney disease experience abnormalities in serum calcium, phosphorus, parathyroid hormone, and vitamin D metabolism. These can lead to vascular calcification (VC), which has been associated with ...
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice
(OXFORD UNIV PRESSOXFORD, 2012)
Atherosclerosis and vascular calcification (VC) progression in chronic kidney disease is favored by disturbances of mineral metabolism. We compared the effect of phosphate binder lanthanum (La) carbonate with sevelamer-HCl ...
Sevelamer and CKD-associated cardiovascular disease: going further, but far from there
(Nature Publishing Group, 2013-09-01)
Cardiovascular disease is a major complication of chronic kidney disease (CKD), and current data support its link to mineral metabolism disturbances. However, there is an intense debate over whether CKD-mineral and bone ...
¿Cuál es la eficacia de sevelamer en el tratamiento de la hiperfosforemia en los pacientes en diálisis?
(Facultad de Medicina. Hospital de Clínicas. Departamento de Farmacología y Terapéutica., 2019)
Comunicado de Seguridad de Farmacovigilancia Nº 036-2019. Actualizacion de informacion de seguridad de sevelamero
(Seguro Social de Salud (EsSalud), 2019-12-10)
El presente comunicado de seguridad aborda el tema del riesgo de alteraciones inflamatorias en el tracto gastrointestinal asociado al uso de sevelamero. En ese sentido, recomienda precauciones debido a este potencial efecto ...